Eurobio Scientific Société anonyme (EPA:ALERS)

Market Cap	250.20M
Revenue (ttm)	162.47M
Net Income (ttm)	2.36M
Shares Out	10.07M
EPS (ttm)	0.22
PE Ratio	110.74
Forward PE	31.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Average Volume	562
Open	24.85
Previous Close	24.85
Day's Range	24.85 - 24.85
52-Week Range	21.80 - 26.50
Beta	0.67
RSI	54.46
Earnings Date	Dec 24, 2025

About EPA:ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune stat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 326
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALERS

Financial Performance

In 2024, EPA:ALERS's revenue was 154.95 million, an increase of 18.60% compared to the previous year's 130.65 million. Earnings were 4.00 million, a decrease of -17.31%.